Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „administering“
Suchtreffer
Begriffe & Kennungen
Abiraterone Accord · 4.5 · Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particula
Eintrag öffnenAbiraterone Accord · 4.5 · Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particula
Eintrag öffnenAbiraterone Krka · 4.5 · 6 administering Abiraterone Krka with medicinal products known to prolong the QT interval or medicinal product
Eintrag öffnenAbiraterone Krka · 4.5 · Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particula
Eintrag öffnenAbiraterone Mylan · 4.5 · Caution is advised when administering with medicinal products activated by or metabolised by CYP2D6, particula
Eintrag öffnenAbrysvo · 4.8 · The safety of administering a single dose of Abrysvo to pregnant individuals at 24-36 weeks of gestation and i
Eintrag öffnenAdvagraf · 4.5 · 13 ciclosporin and tacrolimus is not recommended and care should be taken when administering tacrolimus to pat
Eintrag öffnenAvamys · 4.5 · Caution is recommended when co-administering fluticasone furoate with potent CYP3A inhibitors including cobici
Eintrag öffnenBesremi · 4.5 · Caution must be exercised when administering ropeginterferon alfa-2b in combination with other potentially mye
Eintrag öffnenBosulif · 4.5 · Proton pump inhibitors (PPIs) Caution should be exercised when administering bosutinib concomitantly with PPIs
Eintrag öffnenCholestagel · 4.5 · When administering medicinal products for which alterations in blood levels could have a clinically significan
Eintrag öffnenClopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) · 4.5 · Acetazolamide Caution is recommended when co-administering salicylates with acetazolamide as there is an incre
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Acetazolamide Caution is recommended when co-administering salicylates with acetazolamide as there is an incre
Eintrag öffnenEbilfumin · 4.5 · Probenecid No dose adjustment is required when co-administering with probenecid in patients with normal renal
Eintrag öffnenElebrato Ellipta · 4.5 · Caution is advised when co-administering with strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir, cobicist
Eintrag öffnenEtcamah · 4.5 · When co-administering camizestrant in combination with ribociclib, plus a moderate CYP3A4/5 inducer (including
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Patients with selective IgA deficiency who developed antibodies to IgA, as administering an IgA-containing pro
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.3 · Patients with selective IgA deficiency who developed antibodies to IgA, as administering an IgA-containing pro
Eintrag öffnenGlivec · 4.5 · In Ph+ ALL patients, there is clinical experience of co-administering Glivec with chemotherapy (see section 5.
Eintrag öffnenHemgenix · 4.5 · Before administering etranacogene dezaparvovec to patients receiving potentially hepatotoxic medicinal product
Eintrag öffnen